Abstract
We report the combined use of inhaled nitric oxide (iNO) and sildenafil to selectively lower pulmonary vascular resistance (PVR) and reverse right-to-left shunt flow across a congenital ventricular septal defect (VSD) in a 50-year-old man. The patient developed right-to-left shunt flow with profound hypoxia because of an acute pulmonary embolism superimposed on underlying pulmonary hypertension. The dramatic improvement in oxygenation and PVR with sildenafil plus iNO has been sustained with sildenafil monotherapy. To our knowledge, use of this combination therapy in patients with decompensated pulmonary arterial hypertension (PAH) and a predisposition to right-to-left shunting has not been previously reported.
Copyright 2004 Lippincott Williams and Wilkins
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Administration, Inhalation
-
Administration, Oral
-
Bronchodilator Agents / administration & dosage
-
Bronchodilator Agents / therapeutic use
-
Echocardiography
-
Heart Septal Defects, Ventricular / complications
-
Heart Septal Defects, Ventricular / diagnosis
-
Heart Septal Defects, Ventricular / drug therapy*
-
Humans
-
Hypertension, Pulmonary / diagnosis
-
Hypertension, Pulmonary / drug therapy*
-
Hypertension, Pulmonary / etiology
-
Male
-
Middle Aged
-
Nitric Oxide / administration & dosage
-
Nitric Oxide / therapeutic use
-
Piperazines / administration & dosage
-
Piperazines / therapeutic use
-
Pulmonary Embolism / complications
-
Pulmonary Embolism / diagnosis
-
Pulmonary Embolism / drug therapy*
-
Purines
-
Sildenafil Citrate
-
Sulfones
-
Vascular Resistance / drug effects
-
Vasodilator Agents / administration & dosage
-
Vasodilator Agents / therapeutic use
Substances
-
Bronchodilator Agents
-
Piperazines
-
Purines
-
Sulfones
-
Vasodilator Agents
-
Nitric Oxide
-
Sildenafil Citrate